Catherine Nalpas

3PUBLICATIONS
8CO-AUTHORS
Clinical neuropsychologyToxicology (incl. clinical toxicology)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 03, 2026
Time Course of Rimegepant Effect for Acute Treatment of Migraine in Adults Unsuitable for Triptans: Exploratory Endpoints from a Phase 4, Randomized, Double-Blind, Placebo-Controlled Study.

|Mar 04, 2026
Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial.

Daniel Franjic, Robert J Fountaine, Catherine Nalpas

|Nov 19, 2025
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.

Messoud Ashina, Peter McAllister, Charly Gaul

Pageof 1

Frequent Collaborators

2 joint publications

Robert J Fountaine

1 joint publications

Messoud Ashina

1 joint publications

Peter McAllister

1 joint publications

Charly Gaul